0RNX Stock Overview Provides elderly care, disability care, and psychosocial support for the elderly and people with disabilities primarily in Sweden, Norway, and Denmark. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Ambea AB (publ) Competitors Price History & Performance
Summary of share price highs, lows and changes for Ambea Historical stock prices Current Share Price SEK 96.55 52 Week High SEK 102.40 52 Week Low SEK 49.82 Beta 1.24 1 Month Change 2.88% 3 Month Change 8.36% 1 Year Change 84.97% 3 Year Change 58.28% 5 Year Change 23.78% Change since IPO 17.92%
Recent News & Updates
Chief Financial Officer recently bought kr185k worth of stock Nov 28
Director recently sold kr1.9m worth of stock Nov 11
Third quarter 2024 earnings released: EPS: kr3.14 (vs kr2.30 in 3Q 2023) Nov 07
Ambea AB (publ) Announces Appointments to Nomination Committee Oct 11
Second quarter 2024 earnings released: EPS: kr1.10 (vs kr0.51 in 2Q 2023) Aug 17 Ambea AB (publ) to Report Q2, 2025 Results on Aug 19, 2025 See more updates
Chief Financial Officer recently bought kr185k worth of stock Nov 28
Director recently sold kr1.9m worth of stock Nov 11
Third quarter 2024 earnings released: EPS: kr3.14 (vs kr2.30 in 3Q 2023) Nov 07
Ambea AB (publ) Announces Appointments to Nomination Committee Oct 11
Second quarter 2024 earnings released: EPS: kr1.10 (vs kr0.51 in 2Q 2023) Aug 17 Ambea AB (publ) to Report Q2, 2025 Results on Aug 19, 2025
Ambea AB (publ) to Report Fiscal Year 2024 Results on Feb 12, 2025 Jul 16
CEO & President recently bought kr390k worth of stock May 26
Ambea AB (Publ) Approves Dividend, Payable on 22 May 2024 May 16
Upcoming dividend of kr1.50 per share May 10
First quarter 2024 earnings released: EPS: kr1.25 (vs kr0.77 in 1Q 2023) May 03
Ambea AB (Publ) Proposes Dividend, Payable on 22 May 2024 Apr 12
Dividend increased to kr1.50 Apr 06
Ambea AB (publ) to Report Q3, 2024 Results on Nov 06, 2024 Mar 29
Full year 2023 earnings released: EPS: kr5.07 (vs kr3.89 in FY 2022) Mar 29
Managing Director of Stendi recently bought kr102k worth of stock Mar 25
Independent Chairman recently bought kr377k worth of stock Mar 15 Contemplated Sale of Shares of ACTR Holding AB in Ambea AB Mar 13
Full year 2023 earnings released: EPS: kr5.07 (vs kr3.89 in FY 2022) Feb 08
Ambea AB (publ) to Report Fiscal Year 2023 Final Results on Mar 27, 2024 Jan 27
Director recently bought kr1.5m worth of stock Dec 04
CEO & President recently bought kr229k worth of stock Nov 19
Third quarter 2023 earnings released: EPS: kr2.30 (vs kr2.04 in 3Q 2022) Nov 02 Ambea AB (publ), Annual General Meeting, May 15, 2024
CEO & President recently bought kr176k worth of stock Sep 15
CEO & President recently bought kr218k worth of stock Aug 19 Ambea AB (publ) to Report Q2, 2024 Results on Aug 16, 2024
Second quarter 2023 earnings released: EPS: kr0.51 (vs kr0.91 in 2Q 2022) Aug 18
Ambea AB (publ) to Report Q2, 2023 Results on Aug 17, 2023 Aug 04
CEO & President recently bought kr208k worth of stock Jun 05
Ambea AB (publ) Approves Dividend Payable on 19 May 2023 May 12
CEO & President recently bought kr242k worth of stock May 07
Upcoming dividend of kr1.25 per share at 3.0% yield May 05
CEO & President recently bought kr394k worth of stock Mar 31
Full year 2022 earnings released: EPS: kr3.89 (vs kr2.51 in FY 2021) Mar 29
Chairman recently bought kr272k worth of stock Feb 24
CEO & President recently bought kr280k worth of stock Feb 12
Full year 2022 earnings released: EPS: kr3.89 (vs kr2.51 in FY 2021) Feb 10
Ambea AB (Publ) Proposes Dividend for the Year 2022 Feb 09
Ambea AB (publ) to Report Q3, 2023 Results on Nov 02, 2023 Jan 11
Insider recently bought kr97k worth of stock Dec 10
Ambea AB (publ) to Report Fiscal Year 2022 Final Results on Mar 28, 2023 Dec 06
Less than half of directors are independent Nov 16
Third quarter 2022 earnings released: EPS: kr2.04 (vs kr2.01 in 3Q 2021) Nov 04
Investor sentiment improved over the past week Nov 03
Ambea AB (publ), Annual General Meeting, May 12, 2023 Oct 22
Second quarter 2022 earnings released: EPS: kr0.91 (vs kr0.39 in 2Q 2021) Aug 19 Ambea AB (publ) to Report Q2, 2023 Results on Aug 17, 2023 Ambea AB (publ) Announces Board Appointments
Upcoming dividend of kr1.15 per share May 06
First quarter 2022 earnings released: EPS: kr0.70 (vs kr0.49 in 1Q 2021) May 05
Less than half of directors are independent Apr 27 Ambea AB (Publ) Proposes Dividend, Payable 19 May 2022
Full year 2021 earnings released: EPS: kr2.51 (vs kr3.80 in FY 2020) Apr 01
Lena Hofsberger and Liselott Kilaas Chooses Not to Stand for Re-Election of Ambea's Board Feb 16
Managing Director of Altiden recently bought kr100k worth of stock Feb 12
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Feb 10
Ambea AB (publ) Proposes Dividend for 2021 Feb 09
CEO & President recently bought kr501k worth of stock Dec 18
CEO & President recently bought kr301k worth of stock Nov 27
Third quarter 2021 earnings released: EPS kr2.01 (vs kr1.61 in 3Q 2020) Nov 06
CEO & President recently bought kr306k worth of stock Nov 06
CEO & President recently bought kr495k worth of stock Aug 25
Less than half of directors are independent Aug 04
Ambea AB (publ) Approves Dividend, Payable on 20 May 2021 May 13
Ambea AB (Publ) Provides Revenue Guidance for the Second Quarter of Fiscal Year 2021 May 05
Full year 2020 earnings released: EPS kr3.80 (vs kr2.51 in FY 2019) Apr 02
Insider recently sold kr1.5m worth of stock Mar 13
Insider recently sold kr616k worth of stock Feb 19
Full year 2020 earnings released: EPS kr3.78 (vs kr2.51 in FY 2019) Feb 17
Revenue beats expectations Feb 17 Ambea AB (publ) to Report Q2, 2021 Results on Jul 23, 2021
New 90-day high: kr72.60 Feb 11
New 90-day high: kr71.20 Jan 19
New 90-day high: kr63.70 Dec 29
New 90-day high: kr62.00 Dec 05 Ambea AB (Publ) Appoints Mark Jensen as the Present
Division Manager of Vardaga recently sold kr2.3m worth of stock Nov 12
Ambea AB (publ) to Report Fiscal Year 2020 Results on Feb 16, 2021 Nov 07
Third quarter 2020 earnings released: EPS kr1.61 Nov 07
Revenue misses expectations Nov 07
New 90-day low: kr52.10 Oct 26
New 90-day high: kr60.50 Sep 17
New 90-day high - kr59.00 Sep 02
Earnings released Aug 20 Shareholder Returns 0RNX GB Healthcare GB Market 7D -0.7% -0.05% -0.6% 1Y 85.0% -25.9% 3.1%
See full shareholder returns
Return vs Market: 0RNX exceeded the UK Market which returned 3.1% over the past year.
Price Volatility Is 0RNX's price volatile compared to industry and market? 0RNX volatility 0RNX Average Weekly Movement 3.4% Healthcare Industry Average Movement 5.0% Market Average Movement 4.8% 10% most volatile stocks in GB Market 10.6% 10% least volatile stocks in GB Market 2.6%
Stable Share Price: 0RNX has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: 0RNX's weekly volatility (3%) has been stable over the past year.
About the Company Ambea AB (publ) provides elderly care, disability care, and psychosocial support for the elderly and people with disabilities primarily in Sweden, Norway, and Denmark. It operates through five segments: Nytida, Vardaga, Stendi, Altiden, and Klara. The company offers social care services and schools for children and young people with neuropsychiatric disorders under the Nytida brand; nursing homes and home care services for elderly people under the Vardaga brand; and social care for children, young people, and adults by offering personal assistance, residential care, home care, and elderly care under the Stendi brand.
Show more Ambea AB (publ) Fundamentals Summary How do Ambea's earnings and revenue compare to its market cap? 0RNX fundamental statistics Market cap SEK 8.10b Earnings (TTM ) SEK 604.00m Revenue (TTM ) SEK 13.97b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 0RNX income statement (TTM ) Revenue SEK 13.97b Cost of Revenue SEK 10.23b Gross Profit SEK 3.74b Other Expenses SEK 3.13b Earnings SEK 604.00m
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 12, 2025
Earnings per share (EPS) 7.20 Gross Margin 26.74% Net Profit Margin 4.32% Debt/Equity Ratio 50.3%
How did 0RNX perform over the long term?
See historical performance and comparison Dividends
1.6% Current Dividend Yield
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/26 03:15 End of Day Share Price 2024/12/23 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Ambea AB (publ) is covered by 6 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Erik Moberg Berenberg Kristofer Liljeberg-Svensson Carnegie Investment Bank AB Karl Norén Danske Bank
Show 3 more analysts 
